News Article

Patents for Small Molecule Nucleic Acid Hybrid (SMNH) Prodrug Technology Issued
Date: Mar 23, 2012
Source: ( click here to go to the source)

Featured firm in this article: Spring Bank Pharmaceuticals Inc of Milford, MA

Spring Bank Pharmaceuticals was recently issued patents for its Small Molecule Nucleic Acid Hybrid (SMNH) prodrug technology entitled “Nucleotide and Oligonucleotide prodrugs” in China, Korea, Japan and the US. The prodrug technology facilities oral delivery of SMNH compounds and oligonucleotide anlogs.